How would you manage a rising CA-125 in a young patient on maintenance bevacizumab and olaparib x1 year for IIIC HR-deficient serous ovary cancer whose only finding on PETCT is a 1.5cm pelvic lymph node?

Would you continue her current regimen, refer to Radiation Oncology, change systemic therapy, or consider secondary debulking surgery?